Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 8/20 | 0.68 |
| ▸ | EYA3 | Q99504 | 7/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | PGR | P06401 | 2/20 | 0.67 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.67 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.67 |
| ▸ | DRD1 | P21728 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | PDE4A | P27815 | 1/20 | 0.67 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.67 |
| ▸ | DRD3 | P35462 | 1/20 | 0.67 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25391820 | 0.88 | EYA3 (0.70) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL30258571 | 0.88 | TTR (0.72) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL30258897 | 0.86 | TTR (0.69) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL30258456 | 0.86 | SLC22A12 (0.68) | TTREYA3MEN1ABCB11LMNA | |
| Benziodarone SCHEMBL31326233 | 0.81 | EYA3 (1.00) | TTREYA3MEN1ABCB11LMNA | |
| Benziodarone SCHEMBL308541 | 0.81 | EYA3 (1.00) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL26809506 | 0.77 | SLC22A12 (0.62) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL25393151 | 0.77 | TTR (0.55) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL25391545 | 0.76 | EYA3 (0.70) | TTREYA3MEN1ABCB11LMNA | |
| SCHEMBL30258719 | 0.76 | TTR (0.79) | TTREYA3MEN1ABCB11LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282741-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | INNOVO THERAPEUTICS INC. (KR) | 2025-09-11 | — | — | US | claimed |
| EP-4413981-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Innovo Therapeutics Inc. (KR) | 2024-08-14 | — | — | EP | claimed |
| CN-118043043-A | Benzofuranyl hydroxy phenyl ketone derivative compound or pharmaceutically acceptable salt thereof | 因诺沃治疗有限公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2023059121-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | (주)이노보테라퓨틱스 | 2023-04-13 | — | — | WO | claimed |
| US-20250282741-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | INNOVO THERAPEUTICS INC. (KR) | 2025-09-11 | — | — | US | disclosed |
| EP-4413981-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Innovo Therapeutics Inc. (KR) | 2024-08-14 | — | — | EP | disclosed |
| CN-118043043-A | Benzofuranyl hydroxy phenyl ketone derivative compound or pharmaceutically acceptable salt thereof | 因诺沃治疗有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023059121-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | (주)이노보테라퓨틱스 | 2023-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282741-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | HSPH1, HSP90AA1, HSPD1 | TTR 1428/4885EYA3 1904/4885MEN1 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.